Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Healthcare Advertising Agencies
Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Mydecine Innovations Group Inc
Bullboard Posts
User Avatar Image
(136)
•••
Post by goldwatch69on Apr 01, 2019 8:46am
170 Views
Post# 29562699

6.5 cents in pre market

6.5 cents in pre market
C:NF - New Age Brands Inc. - https://www.newagefarminc.com 08:45:23 EDT
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
NF - C   60.0 0.04 · 0.04 51.0 1.35                0.16  0.025 Mar 29 15:59:59 Mar 26 15 min RT 2¢
CSE - C 60.0 0.04 · 0.04 51.0   0.16  0.025 Mar 29 15:59:59   15 min

 

 

Recent Trades - All 0 today
Time ET Ex Price Change Volume Buyer Seller Markers
08:30:12 O 0.065 -1.285 80,000 1 Anonymous 1 Anonymous  
08:30:09 O 0.065 -1.285 70,000 1 Anonymous 1 Anonymous  
08:30:02 H 0.05 -1.30 30,000 99 Jitney 1 Anonymous  
08:30:01 H 0.05 -1.30 15,000 13 Instinet 1 Anonymous  
08:29:55 H 0.05 -1.30 90,000 99 Jitney 1 Anonymous  
08:29:44 H 0.05 -1.30 10,000 99 Jitney 1 Anonymous  
08:28:33 H 0.05 -1.30 50,000 99 Jitney 1 Anonymous  
08:28:33 O 0.06 -1.29 50,000 1 Anonymous 1 Anonymous  
08:28:30 H 0.06 -1.29 5,000 13 Instinet 1 Anonymous  
               

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities